Skip to main content
. 2022 Jun 30;9:946556. doi: 10.3389/fnut.2022.946556

TABLE 4.

Effects of ferulic acid on lipid profiles and renal indicators in the serum of HFFD-fed rats.

Variable Control Model FAL FAH AP
Lipid profiles
TG (mmol/L) 1.05 ± 0.23 2.30 ± 0.29** 1.39 ± 0.52## 1.41 ± 0.18*,# 1.57 ± 0.33*,##
LDL-C (mmol/L) 0.58 ± 0.10 0.77 ± 0.18* 0.51 ± 0.03# 0.50 ± 0.04# 0.42 ± 0.05##
HDL-C (mmol/L) 1.10 ± 0.12 0.78 ± 0.06** 0.94 ± 0.13*,# 0.99 ± 0.07## 0.94 ± 0.17#
FFA (mmol/L) 0.75 ± 0.09 1.08 ± 0.12** 0.94 ± 0.20* 0.75 ± 0.08## 0.80 ± 0.10##
Renal indicators
UA (μmol/L) 62.46 ± 2.31 91.27 ± 11.90** 75.82 ± 9.74**,# 65.81 ± 7.22## 75.54 ± 3.07**,#
BUN (mg/L) 93.66 ± 7.81 160.01 ± 10.75** 91.31 ± 10.21## 100.82 ± 7.64## 79.51 ± 7.92*,##
CRE (μmol/L) 55.65 ± 1.77 57.09 ± 3.00 55.54 ± 2.62 54.83 ± 2.75 51.04 ± 1.93##

Data are presented as mean ± SD. *p < 0.05, **p < 0.01, vs. Control; #p < 0.05, ##p < 0.01, vs. Model. FAL, low dose of ferulic acid group administered of HFFD mixed with 0.05% ferulic acid; FAH, high dose of ferulic acid administered of HFFD mixed with 0.1% ferulic acid; AP, allopurinol group administered of HFFD mixed with 0.0145% allopurinol.